A Mini-Review of Last Guidelines about Management of Eosinophilic Oesophagitis

Abstract

Background: Eosinophilic oesophagitis is a chronic oesophageal disease that is driven by the immune system. It is defined histologically by mostly eosinophilic inflammation and clinically by symptoms resembling oesophageal dysfunction. Allergens have a significant part in causing this illness. Being an immunologically active organ, the oesophagus can draw in eosinophils in reaction to a variety of triggers.

Aim: The present study highlights about last guidelines about management of Eosinophilic Oesophagitis.

Methods: Numerous nations outside of Africa have recorded cases of eosinophilic oesophagitis, with men between the ages of. 20 and 30 and city dwellers having a higher frequency. There are several disorders linked to this problem, the most significant of which being gastroesophageal reflux disease (GERD).

Results: From a paraclinical point of view, patients have a peripheral eosinophilia, and diagnostic certainty is realized by performing upper endoscopy with biopsy. The recommended treatment has 3 stages, namely diet, drug therapy (such as fluticasone propionate, budesonide and proton-pump inhibitors) and investigations such as upper endoscopy.

Conclusion: The article aims to highlight recent recommendations in international guidelines for the management of eosinophilic oesophagitis, as well as to review its clinical manifestations, genetics, immunopathogenesis diagnosis and treatment. A deeper understanding is needed to inform clinical decisions regarding optimal disease follow-up and the use of long-term maintenance therapy.